BioCentury
ARTICLE | Financial News

Aquestive sets terms for proposed IPO

July 20, 2018 5:32 PM UTC

CNS disease company Aquestive Therapeutics Inc. (Warren, N.J.) revealed terms for its proposed IPO on NASDAQ. In a regulatory filing from July 16, the company proposed to sell 4 million shares at $14-$16.

At the $15 midpoint, Aquestive would raise $60 million and be valued at $360 million. Underwriters are BMO Capital, RBC Capital, Wedbush PacGrow and JMP Securities. In June, the company filed to raise up to $69 million in the offering...

BCIQ Company Profiles

Aquestive Therapeutics Inc.